A link between hepatic glucose production and peripheral energy metabolism via hepatokines

被引:56
作者
Abdul-Wahed, Aya
Gautier-Stein, Amandine
Casteras, Sylvie
Soty, Maud
Roussel, Damien
Romestaing, Caroline
Guillou, Herve
Tourette, Jean-Andre
Pleche, Nicolas
Zitoun, Carine
Gri, Blandine
Sardella, Anne
Rajas, Fabienne
Mithieux, Gilles
机构
[1] INSERM, U855, F-69008 Lyon, France
[2] Univ Lyon, F-69008 Lyon, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] Univ Aleppo, Aleppo, Syria
[5] CNRS, UMR5023, F-69622 Villeurbanne, France
[6] INRA ToxALim, F-31027 Toulouse, France
关键词
Liver; Endogenous glucose production; Hepatokines; Type; 2; diabetes; Obesity; Energy expenditure;
D O I
10.1016/j.molmet.2014.05.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Type 2 diabetes is characterized by a deterioration of glucose tolerance, which associates insulin resistance of glucose uptake by peripheral tissues and increased endogenous glucose production. Here we report that the specific suppression of hepatic glucose production positively modulates whole-body glucose and energy metabolism. We used mice deficient in liver glucose-6 phosphatase that is mandatory for endogenous glucose production. When they were fed a high fat/high sucrose diet, they resisted the development of diabetes and obesity due to the activation of peripheral glucose metabolism and thermogenesis. This was linked to the secretion of hepatic hormones like fibroblast growth factor 21 and angiopoietin-like factor 6. Interestingly, the deletion of hepatic glucose-6 phosphatase in previously obese and insulin-resistant mice resulted in the rapid restoration of glucose and body weight controls. Therefore, hepatic glucose production is an essential lever for the control of whole-body energy metabolism during the development of obesity and diabetes. (c) 2014 The Authors. Published by Elsevier GmbH.
引用
收藏
页码:531 / 543
页数:13
相关论文
共 74 条
[1]
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals [J].
Altarejos, Judith Y. ;
Montminy, Marc .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (03) :141-151
[2]
Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
[3]
Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity [J].
Berglund, Eric D. ;
Li, Candice Y. ;
Bina, Holly A. ;
Lynes, Sara E. ;
Michael, M. Dodson ;
Shanafelt, Armen B. ;
Kharitonenkov, Alexei ;
Wasserman, David H. .
ENDOCRINOLOGY, 2009, 150 (09) :4084-4093
[4]
The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives [J].
Chen, Lei ;
Magliano, Dianna J. ;
Zimmet, Paul Z. .
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (04) :228-236
[5]
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes [J].
Clore, JN ;
Stillman, J ;
Sugerman, H .
DIABETES, 2000, 49 (06) :969-974
[6]
PREDOMINANT ROLE OF GLUCONEOGENESIS IN INCREASED HEPATIC GLUCOSE-PRODUCTION IN NIDDM [J].
CONSOLI, A ;
NURJHAN, N ;
CAPANI, F ;
GERICH, J .
DIABETES, 1989, 38 (05) :550-557
[7]
Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].
Coskun, Tamer ;
Bina, Holly A. ;
Schneider, Michael A. ;
Dunbar, James D. ;
Hu, Charlie C. ;
Chen, Yanyun ;
Moller, David E. ;
Kharitonenkov, Alexei .
ENDOCRINOLOGY, 2008, 149 (12) :6018-6027
[8]
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits [J].
De Vadder, Filipe ;
Kovatcheva-Datchary, Petia ;
Goncalves, Daisy ;
Vinera, Jennifer ;
Zitoun, Carine ;
Duchampt, Adeline ;
Backhed, Fredrik ;
Mithieux, Gilles .
CELL, 2014, 156 (1-2) :84-96
[9]
Pathogenesis of type 2 diabetes mellitus [J].
DeFronzo, RA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) :787-+
[10]
Beta- and alpha-cell dysfunction in type 2 diabetes [J].
Del Prato, S ;
Marchetti, P .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) :775-781